Ironwood Pharmaceuticals, Inc. (IRWD)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 01:25PM EDT. Market open.
| Previous close | 6.42 |
| Open | 6.44 |
| Bid | 6.61 x 100 |
| Ask | 6.63 x 100 |
| Day's range | 6.37 - 6.66 |
| 52-week range | 6.21 - 15.70 |
| Volume | |
| Avg. volume | 4,401,275 |
| Market cap | 1.052B |
| Beta (5Y monthly) | 0.57 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
US$16.33: That's What Analysts Think Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Is Worth After Its Latest Results
It's been a sad week for Ironwood Pharmaceuticals, Inc. ( NASDAQ:IRWD ), who've watched their investment drop 14% to...
- GuruFocus.com
Ironwood Pharmaceuticals Reports Mixed Q1 2024 Results Amid Key Clinical Advancements
Revenue Falls Short of Expectations While Clinical Trials Show Promising Outcomes
- Insider Monkey
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q1 2024 Earnings Call Transcript
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q1 2024 Earnings Call Transcript May 9, 2024 Ironwood Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $0.08927 EPS, expectations were $0.18. Ironwood Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you […]
© 2024 Yahoo. All rights reserved.